Skip to main content
Top
Published in: Malaria Journal 1/2014

Open Access 01-09-2014 | Oral presentation

Are investments in malaria control saving the lives of children? Challenges in using all-cause child mortality for measuring the impact of malaria control programs

Author: Thomas Eisele

Published in: Malaria Journal | Special Issue 1/2014

Login to get access

Excerpt

As global investments to combat malaria have reached over 1.8 billion per year, there is a strong desire by governments and donors to measure the number of deaths prevented from these investments. Much of this funding has gone to African countries where malaria burden is highest, but robust health information systems and vital registration are weakest, which precludes measuring changes in malaria deaths directly. Because malaria accounts for a large proportion of deaths in Africa (15%), assessing trends in all-cause child mortality (ACCM) has become a key indicator for measuring program impact. The objectives of this talk will be to provide a comparison of common epidemiological approaches used for evaluating the impact of malaria control programs on ACCM in the African context. Three examples of impact evaluation approached using ACCM as the primary outcome will be discussed: 1) comparison of ACCM measured by household surveys before and after malaria program introduction or scale-up (aka ‘trends over time’); 2) assessment of the association between exposure to malaria control interventions (e.g. insecticide-treated mosquito nets- ITNs) and ACCM using cross-sectional data; and 3) an analytic frameworks that allow a dose-response relationships to be estimated between changes in sub-national (district) malaria program intensity and ACCM. In doing so, an attempt will be made to discuss the key challenges of using these methods, as well as specific recommendations for their improvement. …
Metadata
Title
Are investments in malaria control saving the lives of children? Challenges in using all-cause child mortality for measuring the impact of malaria control programs
Author
Thomas Eisele
Publication date
01-09-2014
Publisher
BioMed Central
Published in
Malaria Journal / Issue Special Issue 1/2014
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-13-S1-O27

Other articles of this Special Issue 1/2014

Malaria Journal 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine